Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment temporarily suspended in phase III studies of tariquidar

Feb. 25, 2003

Advexin awarded orphan drug designation

Feb. 25, 2003

Alphav integrin antagonists and their use disclosed by 3DP

Feb. 25, 2003

Vertex scientists design novel inhibitors of Src and/or Lck kinases

Feb. 25, 2003

Novel HGF receptor tyrosine kinase inhibitors described by Kirin Brewery

Feb. 24, 2003

New distribution agreements for Foscan in East Europe and Mediterranean

Feb. 21, 2003

Atypical retinoid exerts potent antiproliferative and proapoptotic effects

Feb. 20, 2003

New preclinical data reported for HuMax-EGFr

Feb. 20, 2003

Eligard 30 mg receives FDA approval

Feb. 20, 2003

PhotoCure submits NDA for Metvix to FDA

Feb. 20, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...